Thymic epithelial neoplasms with rhabdomyomatous component: a clinicopathological and immunohistochemical study of 7 cases.


Journal

Human pathology
ISSN: 1532-8392
Titre abrégé: Hum Pathol
Pays: United States
ID NLM: 9421547

Informations de publication

Date de publication:
01 2019
Historique:
received: 09 07 2018
revised: 23 08 2018
accepted: 29 08 2018
pubmed: 16 9 2018
medline: 16 11 2019
entrez: 16 9 2018
Statut: ppublish

Résumé

Seven primary thymic epithelial neoplasms, 3 thymomas and 4 thymic carcinomas, with rhabdomyomatous component are herein described. The patients are 2 women and 5 men between the ages of 42 and 62 years (average, 52 years). Clinically, the patients presented with nonspecific symptoms of cough, chest pain, and dyspnea. None of the patients had history of myasthenia gravis or of previous malignancy. Diagnostic imaging revealed the presence of an anterior mediastinal mass in all the patients. Surgical resection was accomplished in all the cases. The 3 thymoma cases were encapsulated tumors: histologically, 2 were lymphocyte rich (World Health Organization type B1), and 1 was an atypical thymoma (World Health Organization type B3). All the thymic carcinomas were ill-defined tumor masses with infiltrative borders and histologically were high-grade carcinomas. In each tumor, in different proportion, there were easily identifiable areas with rhabdomyomatous component characterized by larger cells with eosinophilic cytoplasm and eccentrically placed nuclei. Immunohistochemical stains in all cases showed clearly demarcated presence of the epithelial component (keratin positive/desmin and myoglobin negative) and the rhabdomyomatous component (desmin and myoglobin positive/keratin negative). The 3 patients with thymoma are alive and without recurrence 3 and 5 years after surgical resection, whereas 3 patients with carcinoma died between 2 and 3 years after surgical resection. One patient with thymic carcinoma was lost to follow-up. The current cases highlight the ubiquitous distribution of myoid cells in different types of thymic epithelial neoplasms.

Identifiants

pubmed: 30217623
pii: S0046-8177(18)30353-8
doi: 10.1016/j.humpath.2018.08.027
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

100-105

Informations de copyright

Copyright © 2018 Elsevier Inc. All rights reserved.

Auteurs

Neda Kalhor (N)

Department of Pathology at the University of Texas, MD Anderson Cancer Center, Houston 77030, TX, USA.

Cesar A Moran (CA)

Department of Pathology at the University of Texas, MD Anderson Cancer Center, Houston 77030, TX, USA. Electronic address: cesarmoran@mdanderson.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH